Beauty Health (SKIN)
Company Description
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.
The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health.
The company was founded in 1997 and is headquartered in Long Beach, California.

Country | United States |
IPO Date | Nov 24, 2020 |
Industry | Household & Personal Products |
Sector | Consumer Defensive |
Employees | 769 |
CEO | Marla Malcolm Beck |
Contact Details
Address: 2165 Spring Street Long Beach, California United States | |
Website | https://www.beautyhealth.com |
Stock Details
Ticker Symbol | SKIN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001818093 |
CUSIP Number | 88331L108 |
ISIN Number | US88331L1089 |
Employer ID | 85-1908962 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Marla Malcolm Beck | President, Chief Executive Officer & Director |
Carrie Caulkins | Chief Marketing Officer |
Michael P. Monahan | Chief Financial Officer |
Celeste Ortiz | Chief Human Resources Officer |
Paul Bokota J.D. | Senior Vice President & General Counsel |
Ronald Menezes | Chief Revenue Officer & Executive Officer |
Sheri Lewis | Chief Supply Chain & Operations Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 19, 2025 | 4 | Filing |
Mar 19, 2025 | 4 | Filing |
Mar 19, 2025 | 4 | Filing |
Mar 19, 2025 | 4 | Filing |
Mar 12, 2025 | 10-K | Annual Report |
Mar 12, 2025 | 8-K | Current Report |
Feb 28, 2025 | 3 | Filing |
Feb 28, 2025 | 3 | Filing |
Feb 28, 2025 | 8-K | Current Report |
Feb 07, 2025 | SCHEDULE 13G/A | [Amend] Filing |